Humana Inc.
- Jurisdiction
United States - LEI
529900YLDW34GJAO4J06 - ISIN
US4448591028 (HUM )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€458.74 84.0% undervalued - Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Read full profile
Fundamentals
- Net revenue
€105.01B - Gross margin
73.7% - EBIT
€2.81B - EBIT margin
2.7% - Net income
€1.34B - Net margin
1.3%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
- Last dividend amount
-
$0.89 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
27.2%
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Gilbert Cisneros | September 12, 2025 | $1.00K–$15.00K |
| Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
| Robert Bresnahan | June 9, 2025 | $1.00K–$15.00K |
| Gilbert Cisneros | June 6, 2025 | $1.00K–$15.00K |
| Gilbert Cisneros | May 6, 2025 | $1.00K–$15.00K |
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Sell |